✦ LIBER ✦

Randomized double-blind study of botulinum toxin type B for sialorrhea in als patients

✍ Scribed by Carlayne E. Jackson; Gary Gronseth; Jeffrey Rosenfeld; Richard J. Barohn; Richard Dubinsky; C. Blake Simpson; April McVey; Pamela P. Kittrell; Ruth King; Laura Herbelin

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 147 KB
Volume: 39
Category: Article
ISSN: 0148-639X
DOI: 10.1002/mus.21213

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Botulinum toxin type B vs. type A in tox

Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial

✍ Eric J. Pappert; Terry Germanson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

## Abstract The objective of this study was to compare efficacy, safety, and duration of botulinum toxin type A (BoNT‐A) and type B (BoNT‐B) in toxin‐naïve cervical dystonia (CD) subjects. BoNT‐naïve CD subjects were randomized to BoNT‐A or BoNT‐B and evaluated in a double‐blind trial at baseline a

Re: Botulinum toxin type B vs. Type a in

Re: Botulinum toxin type B vs. Type a in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial

✍ Joerg Mueller 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Reply: Botulinum toxin type B vs. type A

Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial

✍ Eric J. Pappert 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Botulinum toxin type A for drooling in P

Botulinum toxin type A for drooling in Parkinson's disease: A double-blind, randomized, placebo-controlled study

✍ Giovanni Lagalla; Marzia Millevolte; Marianna Capecci; Leandro Provinciali; Mari 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

To investigate the safety and efficacy of botulinum toxin type A (BoNTX) treatment to reduce sialorrhea in Parkinson's disease (PD), a double-blind, randomized, placebo-controlled study enrolled 32 PD patients complaining of excessive drooling. Patients received either 50 U Botox in each parotid gla

Botulinum toxin A versus B in sialorrhea

Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease

✍ Arianna Guidubaldi; Alfonso Fasano; Tamara Ialongo; Carla Piano; Maurizio Pompil 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB

BotB (botulinum Toxin type B): Evaluatio

BotB (botulinum Toxin type B): Evaluation of safety and tolerability in botulinum toxin type A-Resistant cervical dystonia patients (preliminary study)

✍ Dr. Daniel D. Truong; Paul A. Cullis; Christopher F. O'Brien; Martin Koller; Tim 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

## Abstract Botulinum toxin (BTX) injection is considered the treatment of choice for patients with cervical dystonia (torticollis). We conducted a pilot, open‐label, dose‐escalation study with BTX type B in 12 patients who no longer responded clinically to injections with BTX type A. At the doses